Patents by Inventor Lori Jennings

Lori Jennings has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11241482
    Abstract: The present invention provides for methods and compositions for treating or preventing arthritis and joint injury.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: February 8, 2022
    Assignees: NOVARTIS AG, The Scripps Research Institute
    Inventors: Lori Jennings, Kristen Johnson, Peter Schultz
  • Publication number: 20200108122
    Abstract: The present invention provides for methods and compositions for treating or preventing arthritis and joint injury.
    Type: Application
    Filed: December 20, 2019
    Publication date: April 9, 2020
    Inventors: Lori Jennings, Kristen Johnson, Peter Schultz
  • Patent number: 10555990
    Abstract: The present invention provides for methods and compositions for treating or preventing arthritis and joint injury.
    Type: Grant
    Filed: August 21, 2018
    Date of Patent: February 11, 2020
    Assignees: NOVARTIS AG, THE SCRIPPS RESEARCH INSTITUTE
    Inventors: Lori Jennings, Kristen Johnson, Peter Schultz
  • Publication number: 20190000922
    Abstract: The present invention provides for methods and compositions for treating or preventing arthritis and joint injury.
    Type: Application
    Filed: August 21, 2018
    Publication date: January 3, 2019
    Applicants: Novartis AG, The Scripps Research Institute
    Inventors: Lori Jennings, Kristen Johnson, Peter Schultz
  • Patent number: 10064918
    Abstract: The present invention provides for methods and compositions for treating or preventing arthritis and joint injury.
    Type: Grant
    Filed: September 18, 2015
    Date of Patent: September 4, 2018
    Assignee: Novartis AG
    Inventors: Lori Jennings, Kristen Johnson, Peter Schultz
  • Publication number: 20160213748
    Abstract: The present invention provides for methods and compositions for treating or preventing arthritis and joint injury.
    Type: Application
    Filed: September 18, 2015
    Publication date: July 28, 2016
    Applicants: THE SCRIPPS RESEARCH INSTITUTE, NOVARTIS AG
    Inventors: Lori Jennings, Kristen Johnson, Peter Schultz
  • Patent number: 9139633
    Abstract: The present invention provides for methods and compositions for treating or preventing arthritis and joint injury.
    Type: Grant
    Filed: July 13, 2010
    Date of Patent: September 22, 2015
    Assignees: Novartis AG, The Scripps Research Institute
    Inventors: Kristen Johnson, Lori Jennings, Peter Schultz
  • Publication number: 20120177644
    Abstract: The present invention provides for methods and compositions for treating or preventing arthritis and joint injury.
    Type: Application
    Filed: July 13, 2010
    Publication date: July 12, 2012
    Applicants: THE SCRIPPS RESEARCH INSTITUTE, IRM LLC
    Inventors: Peter G. Schultz, Kristen Johnson, Lori Jennings
  • Patent number: 7972601
    Abstract: Provided are methods and compositions for treating autism spectrum disorders by administering an antioxidant or agent that stabilize or enhance expression of altered neuroligins. An aspect of the disclosure includes site-specific delivery of the antioxidant to the endoplasmic reticulum (ER) to reverse incorrect disulfide binding of the protein neuroligin. Also disclosed is a method of targeting the antioxidant to neuroligin by using the calcium binding or other recognition site of neuroligin to bind the antioxidant. The antioxidant can be cysteamine linked to a molecule which binds to a binding site.
    Type: Grant
    Filed: May 10, 2005
    Date of Patent: July 5, 2011
    Assignee: The Regents of the University of California
    Inventors: Palmer Taylor, Davide Comoletti, Lori Jennings, Robyn Flynn
  • Publication number: 20070180544
    Abstract: Provided are methods and compositions for treating autism spectrum disorders by administering an antioxidant or agent that stabilize or enhance expression of altered neuroligins. An aspect of the disclosure includes site-specific delivery of the antioxidant to the endoplasmic reticulum (ER) to reverse incorrect disulfide binding of the protein neuroligin. Also disclosed is a method of targeting the antioxidant to neuroligin by using the calcium binding or other recognition site of neuroligin to bind the antioxidant. The antioxidant can be cysteamine linked to a molecule which binds to a binding site.
    Type: Application
    Filed: May 10, 2005
    Publication date: August 2, 2007
    Applicant: The Regents of the University of California
    Inventors: Palmer Taylor, Davide Comoletti, Lori Jennings, Robyn Flynn